AU4517893A - An oral formulation for gastric antibacterial treatment as well as a process thereof and the use - Google Patents
An oral formulation for gastric antibacterial treatment as well as a process thereof and the useInfo
- Publication number
- AU4517893A AU4517893A AU45178/93A AU4517893A AU4517893A AU 4517893 A AU4517893 A AU 4517893A AU 45178/93 A AU45178/93 A AU 45178/93A AU 4517893 A AU4517893 A AU 4517893A AU 4517893 A AU4517893 A AU 4517893A
- Authority
- AU
- Australia
- Prior art keywords
- gastric
- well
- oral formulation
- antibacterial treatment
- antibacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9201930A SE9201930D0 (en) | 1992-06-24 | 1992-06-24 | GASTRIC ANTIBACTERIAL TREATMENT |
SE9201930 | 1992-06-24 | ||
PCT/SE1993/000521 WO1994000112A1 (en) | 1992-06-24 | 1993-06-11 | An oral formulation for gastric antibacterial treatment as well as a process thereof and the use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4517893A true AU4517893A (en) | 1994-01-24 |
Family
ID=20386583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU45178/93A Abandoned AU4517893A (en) | 1992-06-24 | 1993-06-11 | An oral formulation for gastric antibacterial treatment as well as a process thereof and the use |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU4517893A (en) |
IS (1) | IS4030A (en) |
SE (1) | SE9201930D0 (en) |
SI (1) | SI9300330A (en) |
WO (1) | WO1994000112A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0995447A1 (en) * | 1993-09-09 | 2000-04-26 | Takeda Chemical Industries, Ltd. | Formulation comprising antibacterial substance and antiulcer substance |
AU682764B2 (en) * | 1994-04-01 | 1997-10-16 | Tsumura & Co. | Process for producing sustained-release tablets and enteric tablets |
JP2977907B2 (en) * | 1994-05-06 | 1999-11-15 | ファイザー・インコーポレーテッド | Controlled release dosage form of azithromycin |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
IL119627A (en) | 1996-11-17 | 2002-03-10 | Yissum Res Dev Co | PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT |
SE9700885D0 (en) * | 1997-03-12 | 1997-03-12 | Astra Ab | New pharmaceutical formulation |
CA2282531A1 (en) | 1997-03-25 | 1998-10-01 | Takeda Chemical Industries, Ltd. | Gastrointestinal mucosa-adherent pharmaceutical composition |
GB9710699D0 (en) * | 1997-05-24 | 1997-07-16 | Danbiosyst Uk | Gastro-retentive controlled release system |
US6694692B2 (en) | 1998-10-16 | 2004-02-24 | Francesco Piccone | Modular formwork elements and assembly |
CA2520321A1 (en) * | 2003-04-04 | 2004-10-14 | Pharmacia Corporation | Oral extended release compressed tablets of multiparticulates |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
AP2006003704A0 (en) * | 2004-01-06 | 2006-08-31 | Panacea Biotec Ltd | Controlled release pharmaceutical composition comprising an acid insoluble polymer and a bioadhesivepolymer |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
EP1784167A2 (en) * | 2004-08-27 | 2007-05-16 | Spherics, Inc. | Multi-layer tablets and bioadhesive dosage forms |
US20090111788A1 (en) * | 2006-03-24 | 2009-04-30 | Rajesh Jain | Antibiotic compositions of modified release and process of production thereof |
RU2006132127A (en) * | 2006-09-06 | 2008-03-20 | Государственное Учреждение Научный Центр Здоровьядетей Российской Академии Медицинских Наук (Гу Нцзд Рамн) (Ru) | APPLICATION OF NIFUROXASIDE AS A COMPONENT OF COMBINED MEDICINE THERAPY OF DISEASES ASSOCIATED WITH HELICOBACTER PYLORI, AND A METHOD OF TREATMENT AIMED AT ERADICATION OF AN ACTIVATOR |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9010039D0 (en) * | 1990-05-03 | 1990-06-27 | Reckitt & Colmann Prod Ltd | Medicament preparation |
CA2085342A1 (en) * | 1990-06-14 | 1991-12-15 | Milton R. Kaplan | Stable aqueous drug suspensions |
IL100323A0 (en) * | 1990-12-11 | 1992-09-06 | Brocades Pharma Bv | Heterocyclic carboxylic esters,their preparation and their use for the preparation of gastro-intestinal medicines |
-
1992
- 1992-06-24 SE SE9201930A patent/SE9201930D0/en unknown
-
1993
- 1993-06-09 IS IS4030A patent/IS4030A/en unknown
- 1993-06-11 AU AU45178/93A patent/AU4517893A/en not_active Abandoned
- 1993-06-11 WO PCT/SE1993/000521 patent/WO1994000112A1/en active Application Filing
- 1993-06-23 SI SI9300330A patent/SI9300330A/en unknown
Also Published As
Publication number | Publication date |
---|---|
SE9201930D0 (en) | 1992-06-24 |
IS4030A (en) | 1993-12-25 |
WO1994000112A1 (en) | 1994-01-06 |
SI9300330A (en) | 1993-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7545594A (en) | Implantable device for the treatment of aedemas | |
AU5975694A (en) | Electrotherapeutic apparatus | |
AU7931194A (en) | Apparatus for treatment of the oral cavity | |
AU2748892A (en) | Surgical apparatus | |
AU3888793A (en) | Novel medicament | |
AU4517893A (en) | An oral formulation for gastric antibacterial treatment as well as a process thereof and the use | |
AU3138093A (en) | Patient transfer apparatus | |
AU6801694A (en) | The treatment of small animals | |
AU1433292A (en) | Material treatment apparatus | |
AU1535292A (en) | Ozonator apparatus | |
AU2312392A (en) | Skin treatment device | |
AU5019196A (en) | Concomitant treatment with oral bismuth compounds | |
AU2783292A (en) | Fluid treatment apparatus | |
AU2649092A (en) | Desulphurisation treatment | |
AU4840893A (en) | Surgical apparatus | |
AU6927894A (en) | 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions | |
AU5627796A (en) | Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury | |
AU5611894A (en) | Extended duration antacid product | |
AU2676192A (en) | Treatment devices | |
AU6387994A (en) | Device for medical treatment | |
AU3279993A (en) | A device for the treatment/purification of sewage-effluent | |
AU4374893A (en) | Cuspidor | |
AU1453492A (en) | Antiarteriosclerotic agent, a process for the preparation thereof and the use thereof | |
AU4379893A (en) | Oral decongestant product | |
AU3049692A (en) | Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same |